Introduction: Since mid-April 2020, infection with coronavirus disease of 2019 (COVID-19)
has affected more than 2 million people worldwide. Little is known about the effects of …

Objectives The new coronavirus SARS-CoV-2 (COVID-19) first appeared in Turkey in March
2020, spread rapidly, and caused many deaths. Although COVID-19 is mostly a respiratory …

The study aims to present the incidence of COVID-19 in pediatric patients undergoing renal
replacement therapy (RRT) and to compare the severity and outcomes of the disease …

As of mid-April 2020, the coronavirus disease of 2019 (COVID-19) pandemic has affected
more than 2 million people and caused 135 000 deaths worldwide. Not much is known …

Underlying comorbid illness is a known risk factor for severe coronavirus disease-2019
(COVID-19). Clinical course of COVID-19 in children with primary kidney disease is not well …

Background/aim: There is limited data on COVID-19 disease in children with kidney disease.
We aimed to investigate the characteristics and prognosis of COVID-19 in pediatric …

The presentation of novel coronavirus disease 2019 (COVID-19) in children with kidney
disease is largely unknown. We report on 2 children with kidney disease not receiving long …

Abstract Background and Aim: Despite several studies about COVID-19, many factors
remain unknown. Apart from pulmonary involvement, the other systemic association needs …

Coronavirus disease-2019 (COVID-19) started in late December 2019 in Wuhan, China, and
declared as a pandemic by the World Health Organization by mid-March due to increase …

Background COVID-19 is clinically characterized by high rates of transmission, and
pathological abnormalities. Pediatric patients with CKD are at high risk of COVID-19 …